Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Meridian Bioscience Company Profile (NASDAQ:VIVO)

Consensus Ratings for Meridian Bioscience (NASDAQ:VIVO) (?)
Ratings Breakdown: 1 Sell Rating(s)
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: $19.70 (10.86% upside)

Analysts' Ratings History for Meridian Bioscience (NASDAQ:VIVO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/3/2014ZacksDowngradeNeutral -> Underperform$18.40ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Cowen and CompanyLower Price Target$24.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityBoost Price TargetHold$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013WedbushUpgradeUnderperform -> Neutral$17.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
7/16/2013Cowen and CompanyDowngradeOutperform -> Market Perform$23.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
4/26/2013Craig HallumDowngradeBuy -> Hold$24.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013SidotiInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/17/2012Robert W. BairdBoost Price TargetOutperform$22.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
11/29/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
11/28/2012WedbushDowngradeNeutral -> Underperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/21/2012 forward)
Discuss Meridian Bioscience